Skip to main content
Premium Trial:

Request an Annual Quote

Leonard Herzenberg, Leonore Herzenberg, Krishna Kodukula, Stephen Chang, Gerald Newmin, Cisbio International

Premium

Migrations

Invitrogen said this week that it has formed a flow cytometry scientific advisory board to be chaired by Leonard Herzenberg. Invitrogen also said that Leonore Herzenberg, Leonard's wife, will join the board as a member.

The Herzenbergs are both professors at Stanford University, and run the shared flow cytometry facility there. Len Herzenberg invented the fluorescence-activated cell sorter, and along with Lee has developed several methods and instrumentation related to flow cytometry. Invitrogen said the advisory board will help guide the company's efforts in product development for immunology, flow cytometry, and cell biology.


SRI International this week said that Krishna Kodukula has joined its biosciences division as senior director of system biology. Kodukula will help establish new programs and expand business opportunities, working with SRI's Center of Excellence in Infectious Disease and Biodefense, and Center of Excellence in Computational Biology, SRI said.

Kodukula joins SRI from Sarnoff, an SRI subsidiary. Prior to his time at Sarnoff, Kodukula co-founded Small Molecule Therapeutics and Pyxis Technology Solutions. He has also been an investigator with Bristol-Myers Squibb Pharmaceutical Research Institute and a fellow at the Roche Institute of Molecular Biology. He holds a PhD in biochemistry and botany from Utkal University in India.


MultiCell Technologies said this week that it has appointed Stephen Chang as CEO. He will also continue in his current role as president of MultiCell Technologies. Outgoing CEO Gerald Newmin will continue in his role as co-chairman and secretary of the company, MultiCell said. Chang joined MultiCell as president in 2005.

 

Products

Cisbio International this week announced the release of its second IP-One assay, called IP-One ELISA, at the GPCR Congress in Barcelona, Spain. The new assay complements Cisbio's existing IP-One HTRF assay to create a portfolio of assays for inositol(1)phosphate quantification and GPCR screening, the company said.

IP-One ELISA is a monoclonal antibody-based assay that detects IP1, a major product of the phosphatidyl inositol cascade, which correlates with Gq-coupled activity, Cisbio said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.